15.72
price up icon1.09%   0.17
after-market Handel nachbörslich: 15.72
loading
Schlusskurs vom Vortag:
$15.55
Offen:
$16.05
24-Stunden-Volumen:
1.27M
Relative Volume:
0.97
Marktkapitalisierung:
$1.45B
Einnahmen:
$2.98B
Nettoeinkommen (Verlust:
$-300.00M
KGV:
-4.6235
EPS:
-3.4
Netto-Cashflow:
$225.00M
1W Leistung:
+10.39%
1M Leistung:
+38.62%
6M Leistung:
+150.72%
1J Leistung:
-22.45%
1-Tages-Spanne:
Value
$15.43
$16.33
1-Wochen-Bereich:
Value
$14.02
$16.94
52-Wochen-Spanne:
Value
$3.97
$20.86

Fortrea Holdings Inc Stock (FTRE) Company Profile

Name
Firmenname
Fortrea Holdings Inc
Name
Telefon
877-495-0816
Name
Adresse
8 MOORE DRIVE, DURHAM
Name
Mitarbeiter
14,500
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-03
Name
Neueste SEC-Einreichungen
Name
FTRE's Discussions on Twitter

Vergleichen Sie FTRE mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
FTRE
Fortrea Holdings Inc
15.72 1.44B 2.98B -300.00M 225.00M -3.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.04 113.14B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
741.29 78.49B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
877.94 54.76B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
397.55 54.51B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
INSM
Insmed Inc
197.01 41.64B 447.02M -1.18B -906.14M -6.1812

Fortrea Holdings Inc Stock (FTRE) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-12-11 Hochstufung Citigroup Neutral → Buy
2025-08-04 Hochstufung Robert W. Baird Neutral → Outperform
2025-05-02 Eingeleitet Truist Hold
2025-04-10 Herabstufung Barclays Equal Weight → Underweight
2024-12-11 Herabstufung Citigroup Buy → Neutral
2024-12-06 Herabstufung Robert W. Baird Outperform → Neutral
2024-09-25 Herabstufung Jefferies Buy → Hold
2024-08-08 Herabstufung Evercore ISI Outperform → In-line
2024-07-24 Fortgesetzt Barclays Equal Weight
2024-06-06 Eingeleitet Goldman Neutral
2024-05-29 Eingeleitet TD Cowen Hold
2024-05-28 Eingeleitet Mizuho Neutral
2024-03-22 Eingeleitet Robert W. Baird Neutral
2024-03-06 Eingeleitet Deutsche Bank Hold
2024-01-05 Eingeleitet William Blair Mkt Perform
2024-01-04 Eingeleitet Jefferies Buy
2023-12-11 Hochstufung Citigroup Neutral → Buy
2023-12-01 Hochstufung Evercore ISI In-line → Outperform
2023-11-14 Hochstufung Barclays Equal Weight → Overweight
2023-10-19 Eingeleitet Citigroup Neutral
2023-09-14 Eingeleitet Evercore ISI In-line
2023-08-16 Eingeleitet Barclays Equal Weight
2023-08-07 Eingeleitet BofA Securities Underperform
Alle ansehen

Fortrea Holdings Inc Aktie (FTRE) Neueste Nachrichten

pulisher
Dec 13, 2025

Liquidity Mapping Around (FTRE) Price Events - news.stocktradersdaily.com

Dec 13, 2025
pulisher
Dec 13, 2025

Beck Mack & Oliver LLC Sells 916,179 Shares of Fortrea Holdings Inc. $FTRE - MarketBeat

Dec 13, 2025
pulisher
Dec 12, 2025

Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. ... - Bakersfield.com

Dec 12, 2025
pulisher
Dec 12, 2025

Notice to Long-Term Shareholders of Cytokinetics, Inc. - GlobeNewswire

Dec 12, 2025
pulisher
Dec 12, 2025

Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf - GlobeNewswire Inc.

Dec 12, 2025
pulisher
Dec 12, 2025

Fortrea (NASDAQ:FTRE) Shares Gap UpShould You Buy? - MarketBeat

Dec 12, 2025
pulisher
Dec 12, 2025

1,029,700 Shares in Fortrea Holdings Inc. $FTRE Acquired by Bank of Nova Scotia - MarketBeat

Dec 12, 2025
pulisher
Dec 11, 2025

Why Fortrea (FTRE) Stock Is Up Today - Finviz

Dec 11, 2025
pulisher
Dec 11, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fortrea Holdings, Inc. (FTRE) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Dec 11, 2025
pulisher
Dec 11, 2025

Important Notice to Long-Term Shareholders of Alexandria - GlobeNewswire

Dec 11, 2025
pulisher
Dec 11, 2025

Citigroup Upgrades Fortrea Holdings to Buy From Neutral - marketscreener.com

Dec 11, 2025
pulisher
Dec 10, 2025

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Enidnews.com

Dec 10, 2025
pulisher
Dec 10, 2025

Fortrea (NASDAQ:FTRE) Shares Up 5.5%Still a Buy? - MarketBeat

Dec 10, 2025
pulisher
Dec 09, 2025

Fortrea Holdings, Inc. (FTRE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Dec 09, 2025
pulisher
Dec 09, 2025

Kennedy Capital Management LLC Sells 111,459 Shares of Fortrea Holdings Inc. $FTRE - MarketBeat

Dec 09, 2025
pulisher
Dec 08, 2025

Attention Long-Term Shareholders of Cytokinetics, Inc. - GlobeNewswire

Dec 08, 2025
pulisher
Dec 07, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdings, Inc. (FTRE) And Encourages Investors to Connect - ACCESS Newswire

Dec 07, 2025
pulisher
Dec 07, 2025

Fortrea Holdings Inc. (NASDAQ:FTRE) Surges 27% Yet Its Low P/S Is No Reason For Excitement - simplywall.st

Dec 07, 2025
pulisher
Dec 06, 2025

Fortrea Holdings (NASDAQ:FTRE) NASDAQ Index Fund Biopharma Power - Kalkine Media

Dec 06, 2025
pulisher
Dec 05, 2025

Fortrea (NASDAQ:FTRE) Stock Price Down 5.7%Time to Sell? - MarketBeat

Dec 05, 2025
pulisher
Dec 05, 2025

Fortrea, SCTbio announce strategic collaboration agreement - MSN

Dec 05, 2025
pulisher
Dec 05, 2025

How Fortrea Holdings Inc. (K67) stock compares with market leadersMarket Sentiment Report & Technical Pattern Alert System - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

What dividend safety score for Fortrea Holdings Inc. stockPortfolio Return Report & Low Risk High Win Rate Picks - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Fortrea Holdings Inc. (NASDAQ:FTRE) Receives Average Recommendation of "Hold" from Analysts - MarketBeat

Dec 05, 2025
pulisher
Dec 04, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Fortrea Holdings, Inc. (FTRE) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Dec 04, 2025
pulisher
Dec 04, 2025

Will Fortrea Holdings Inc. (K67) stock outperform global peersJuly 2025 Decliners & Reliable Volume Spike Trade Alerts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Fortrea (NASDAQ:FTRE) Shares Up 10.1%Time to Buy? - MarketBeat

Dec 04, 2025
pulisher
Dec 04, 2025

SCTbio and Fortrea forge strategic collaboration to accelerate cell and gene therapy development and delivery - marketscreener.com

Dec 04, 2025
pulisher
Dec 04, 2025

Fortrea, SCTbio Collaborate Over Cell, Gene Therapy Development, Delivery - marketscreener.com

Dec 04, 2025
pulisher
Dec 04, 2025

SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery - The Globe and Mail

Dec 04, 2025
pulisher
Dec 04, 2025

Capital Fund Management S.A. Grows Stake in Fortrea Holdings Inc. $FTRE - MarketBeat

Dec 04, 2025
pulisher
Dec 04, 2025

Geode Capital Management LLC Increases Stake in Fortrea Holdings Inc. $FTRE - MarketBeat

Dec 04, 2025
pulisher
Dec 03, 2025

Fortrea (FTRE) Valuation Check After Investigation into Alleged Overstated Revenue, Cost Savings, and 2025 EBITDA Targets - Yahoo Finance

Dec 03, 2025
pulisher
Dec 03, 2025

Improved Revenues Required Before Fortrea Holdings Inc. (NASDAQ:FTRE) Stock's 26% Jump Looks Justified - 富途牛牛

Dec 03, 2025
pulisher
Dec 03, 2025

Brandes Investment Partners LP Acquires 94,448 Shares of Fortrea Holdings Inc. $FTRE - MarketBeat

Dec 03, 2025
pulisher
Dec 03, 2025

Is Fortrea Holdings Inc. stock trading at a premium valuationJuly 2025 Gainers & Weekly Return Optimization Alerts - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

Fortrea (FTRE) Valuation Check as Legal Probe Questions Revenue Recognition and 2025 EBITDA Targets - simplywall.st

Dec 02, 2025
pulisher
Dec 02, 2025

Levi & Korsinsky Notifies Fortrea Holdings Inc. (FTRE) Investors - The National Law Review

Dec 02, 2025
pulisher
Dec 02, 2025

Why (FTRE) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com

Dec 02, 2025
pulisher
Dec 02, 2025

Transcript : Fortrea Holdings Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-02-2025 01 - marketscreener.com

Dec 02, 2025
pulisher
Dec 02, 2025

Important Notice to Long-Term Shareholders of Cytokinetics, - GlobeNewswire

Dec 02, 2025
pulisher
Dec 02, 2025

Will Fortrea Holdings Inc. (K67) stock benefit from sector leadership2025 Big Picture & Low Risk Entry Point Tips - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

SG Americas Securities LLC Reduces Position in Fortrea Holdings Inc. $FTRE - MarketBeat

Dec 02, 2025
pulisher
Dec 02, 2025

How strong is Fortrea Holdings Inc. stock revenue growthTrade Exit Summary & Real-Time Buy Zone Alerts - Newser

Dec 02, 2025
pulisher
Nov 30, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdi - The National Law Review

Nov 30, 2025
pulisher
Nov 30, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdings, Inc. (FTRE) And Encourages Stockholders to Connect - ACCESS Newswire

Nov 30, 2025
pulisher
Nov 29, 2025

Is Fortrea Holdings Inc. stock a safe haven assetCEO Change & Detailed Earnings Play Strategies - BỘ NỘI VỤ

Nov 29, 2025
pulisher
Nov 29, 2025

Envestnet Asset Management Inc. Sells 69,467 Shares of Fortrea Holdings Inc. $FTRE - MarketBeat

Nov 29, 2025
pulisher
Nov 27, 2025

Fortrea Holdings, Inc. (FTRE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Nov 27, 2025
pulisher
Nov 27, 2025

Can Fortrea Holdings Inc. stock maintain growth trajectory2025 Fundamental Recap & AI Enhanced Trading Signals - moha.gov.vn

Nov 27, 2025
pulisher
Nov 26, 2025

Fortrea (NASDAQ:FTRE) Stock Price Up 7.4%What's Next? - MarketBeat

Nov 26, 2025

Finanzdaten der Fortrea Holdings Inc-Aktie (FTRE)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Fortrea Holdings Inc-Aktie (FTRE) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Parks Robert
Chief Accounting Officer
Sep 16 '25
Sale
9.95
7,338
73,013
19,046
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Kapitalisierung:     |  Volumen (24h):